Literature DB >> 21803599

Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae.

Antonietta Rizzo1, Marina Di Domenico, Caterina Romano Carratelli, Nello Mazzola, Rossella Paolillo.   

Abstract

Chlamydia pneumoniae is an obligate intracellular Gram-negative bacterium that causes recurrent pharyngitis, pneumonia and chronic inflammation induced by cycles of persistence and productive infection that might also explain the association with chronic diseases. The aim of this study was to determine whether C. pneumoniae can invade and survive within human osteoblasts and whether this infection elicits the secretion of proinflammatory cytokines. Our results demonstrated that C. pneumoniae was able to infect the SaOS-2 osteoblastic cell line and to replicate in the osteoblasts in a time-dependent manner and was associated to an increase in the cell number and cell viability. In addition, infection of the SaOS-2 cell line with C. pneumoniae at MOI of 4 is correlated to a proinflammatory response. Infected osteoblasts produced increased levels of cytokines IL-6, IL-8, IL-17, and IL-23. The production of cytokines increased with subsequent interaction between osteoblasts and monocytes and the maximum levels of cytokines released were detected 72 h after infection with C. pneumoniae. Thus, controlling the release of chemokines, e.g., IL-23, may be a therapeutic strategy for preventing inflammatory bone disease and counteract inflammation and bone destruction.
Copyright © 2011. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803599     DOI: 10.1016/j.cyto.2011.06.027

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: a prospective cohort study.

Authors:  Mohammad Reza Kalantarhormozi; Majid Assadi; Katayoun Vahdat; Kamyar Asadipooya; Afshin Ostovar; Katayoun Raissi; Hossein Darabi; Shokrollah Farrokhi; Sina Dobaradaran; Maryam Farrokhnia; Iraj Nabipour
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

2.  Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?

Authors:  M Di Pietro; G Schiavoni; V Sessa; F Pallotta; G Costanzo; R Sessa
Journal:  Osteoporos Int       Date:  2012-11-16       Impact factor: 4.507

3.  Pulsed electromagnetic fields increased the anti-inflammatory effect of A₂A and A₃ adenosine receptors in human T/C-28a2 chondrocytes and hFOB 1.19 osteoblasts.

Authors:  Fabrizio Vincenzi; Martina Targa; Carmen Corciulo; Stefania Gessi; Stefania Merighi; Stefania Setti; Ruggero Cadossi; Mary B Goldring; Pier Andrea Borea; Katia Varani
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

4.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

Review 5.  Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion.

Authors:  Marina Di Domenico; Antonio Giordano
Journal:  Oncotarget       Date:  2017-05-30

Review 6.  Insights Into Host Cell Cytokines in Chlamydia Infection.

Authors:  Wenjing Xiang; Nanyan Yu; Aihua Lei; Xiaofang Li; Shui Tan; Lijun Huang; Zhou Zhou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

7.  Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis.

Authors:  Rosa Bellmann-Weiler; Andrea Schroll; Sabine Engl; Manfred Nairz; Heribert Talasz; Markus Seifert; Guenter Weiss
Journal:  Immunobiology       Date:  2012-11-21       Impact factor: 3.144

8.  Human blood monocytes support persistence, but not replication of the intracellular pathogen C. pneumoniae.

Authors:  Tanja Buchacher; Herbert Wiesinger-Mayr; Klemens Vierlinger; Beate M Rüger; Gerold Stanek; Michael B Fischer; Viktoria Weber
Journal:  BMC Immunol       Date:  2014-12-09       Impact factor: 3.615

Review 9.  The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?

Authors:  Felice Crocetto; Mariarosaria Boccellino; Biagio Barone; Erika Di Zazzo; Antonella Sciarra; Giovanni Galasso; Giuliana Settembre; Lucio Quagliuolo; Ciro Imbimbo; Silvia Boffo; Italo Francesco Angelillo; Marina Di Domenico
Journal:  Nutrients       Date:  2020-08-31       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.